OGI.V - OrganiGram Holdings Inc.

TSXV - TSXV Delayed Price. Currency in CAD
8.77
-0.13 (-1.46%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close8.90
Open9.07
Bid8.78 x 0
Ask8.78 x 0
Day's Range8.74 - 9.19
52 Week Range3.86 - 10.03
Volume1,266,119
Avg. Volume1,723,657
Market Cap1.333B
Beta (3Y Monthly)4.92
PE Ratio (TTM)27.84
EPS (TTM)0.31
Earnings DateJul 27, 2017 - Jul 28, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.66
  • Thomson Reuters StreetEvents2 days ago

    Edited Transcript of OGI.V earnings conference call or presentation 15-Apr-19 12:00pm GMT

    Q2 2019 OrganiGram Holdings Inc Earnings Call

  • Does The Data Make OrganiGram Holdings Inc. (CVE:OGI) An Attractive Investment?
    Simply Wall St.3 days ago

    Does The Data Make OrganiGram Holdings Inc. (CVE:OGI) An Attractive Investment?

    As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean, I look at stocks holistically, from their financial health to their future outlook. In the case of OrganiGram Holdings...

  • CNW Group4 days ago

    Cannabis Brief: Major Retail Stores Clearing Shelves to Carry CBD Infused Products

    PALM BEACH, Florida , April 17, 2019 /CNW/ -- The projections for the legal & CBD cannabis markets seem to get higher with every new arrival and big box and brick & mortar retailers of all sizes have taken ...

  • Market Exclusive5 days ago

    Market Morning: Chevron Beats Ecuador, Sanders Winning, Volkswagen Losing, Pot Delivery Problems

    Chevron Up $9.5B in Ruling to Negate Ruling to Force it to Pay $9.5B to Ecuador Prepare for a series of confusing negations of double and triple negatives. The case involves Chevron (NYSE:CVX) and Ecuador, generally in the news these days after the arrest of Julian Assange. This time they’re in the news for their […]The post Market Morning: Chevron Beats Ecuador, Sanders Winning, Volkswagen Losing, Pot Delivery Problems appeared first on Market Exclusive.

  • The Canadian Press5 days ago

    Most actively traded companies on the TSX

    Some of the most active companies traded Monday on the Toronto Stock Exchange:Toronto Stock Exchange (16,480.53, up 81.06 points).ProMetic Life Sciences Inc. (TSX:PLI). Down nine cents, or 58.06 per cent to 6.5 cents on 27 million shares.Bombardier Inc. (TSX:BBD.B). Down eight cents, or 2.95 per cent, to $2.63 on 14 million shares.Crescent Point Energy Corp. (TSX:CPG). Energy. Unchanged at $5.64 on 8.3 million shares.Aphria Inc. (TSX:APHA). Health care. Down $1.91, or 14.24 per cent, to $1.91 on 8.2 million sharesEncana Corp. (TSX:ECA). Energy. Down 23 cents, or 2.28 per cent, to $9.85 on 7.1 million shares.Aurora Cannabis Inc. (TSX:ACB). Health care. Down 46 cents, or 3.89 per cent, to $11.37 on 6.6 million shares.Companies reporting:Aphria Inc. — The cannabis company's first full quarter of sales since the legalization of recreational cannabis fell short of investor expectations after the company posted a steep quarterly loss, a $50-million impairment charge related to its Latin America operations and announced that Green Growth Brands had dropped its hostile takeover offer. Although the Leamington, Ont.-based pot producer saw net revenue soar by more than 600 per cent to $73.8 million during its third quarter ended Feb. 28, it posted a net loss of $108.2 million. That's compared with net revenues of $10.3 million and net profits of $12.9 million during the same period a year earlier.Organigram Holdings Inc. (TSXV:OGI). Down 96 cents, or 10.21 per cent to $8.44. Organigram swung to a loss of $6.4 million in its latest quarter as its revenue soared in its first full quarter of adult-use recreational sales. The Moncton-based company saw revenue rise sharply to $26.9 million during the three-month period ended Feb. 28, up from $3.4 million a year earlier and topping estimates. However, Organigram's cost of sales also spiked to $10.9 million, compared to $1.8 million during the same period a year ago.CIBC (TSX:CM). Down 40 cents to $110.35. Canadian Imperial Bank of Commerce is shuffling its leadership deck in a series of moves effective today that includes appointing Ed Dodig, CEO Victor Dodig's brother, to head retail investment firm CIBC Wood Gundy. In internal memos provided to The Canadian Press, the bank says the changes are being made to sharpen client focus and develop leadership capabilities. Ed Dodig is to replace Peter Lee, who will become executive vice-president of banking centres, leading personal and small business banking operations in the retail bank. CIBC says Ed Dodig has had an integral role in the growth of its global markets business, most recently leading its equity markets team, a role that will fall to Anton Erdody on an interim basis.Lundin Mining Corp. (TSX:LUN). Up 55 cents, or 8.05 per cent to $7.38. Lundin Mining has signed a deal to buy the Chapada copper-and-gold mine in Brazil from Yamana Gold Inc. in a deal worth more than US$800 million. Under the agreement, Lundin will pay US$800 million in cash for the mine while Yamana will retain a 2.0 per cent net smelter return royalty on future gold production from the Suruca gold deposit. Yamana will also receive contingent payments of up to US$125 million over five years if certain gold price thresholds are met and contingent consideration of US$100 million on potential construction of a pyrite roaster.The Canadian Press

  • Market Exclusive6 days ago

    Cannabis Stock News Daily Roundup April 15

    Neptune Wellness Solutions (NASDAQ: NEPT) (TSX: NEPT) announced that its Solutions Business has started offering product development solutions with hemp-derived ingredients to business customers in the U.S. A U.S.-based supply chain of licensed hemp extract producers has been established, and initial purchase orders are now being processed, the company said in a statement this morning. BLOCKSTRAIN […]The post Cannabis Stock News Daily Roundup April 15 appeared first on Market Exclusive.

  • Organigram revenue soars in first full quarter of recreational sales
    The Canadian Press6 days ago

    Organigram revenue soars in first full quarter of recreational sales

    Cannabis producer Organigram Holdings Inc. swung to a loss of $6.4 million in its latest quarter as its revenue soared in its first full quarter of adult-use recreational sales.The Moncton-based company saw revenue rise sharply to $26.9 million during the three-month period ended Feb. 28, up from $3.4 million a year earlier and topping estimates.However, Organigram's cost of sales also spiked to $10.9 million, compared to $1.8 million during the same period a year ago.Chief executive Greg Engel said various factors contributed to the increase in cost, including additional staff as it moved to round-the-clock production. He also cited Organigram's move to supply more pre-rolled joints, which are costlier to produce."That was a strategic initiative of ours, there is a demand and an unmet need for pre-rolls out there... It's a way to get as much of our product in consumers' hands," he said in an interview. Its latest revenue numbers beat street expectations of $23.77 million, according to analysts surveyed by Thomson Reuters Eikon. However, the cannabis producer's earnings per share fell short of analyst expectations.The company says its loss amounted to five cents per diluted share for the quarter, compared with a profit of $1.1 million or a penny per diluted share a year earlier. Analysts had expected earnings of one cent per share during the quarter.Shares of Organigram were down roughly 6.6 per cent on the TSX Venture Exchange in early afternoon at $8.78.The cannabis producer's loss came as sales and administrative costs rose to $2.6 million compared with $1.7 million a year ago. Sales and marketing costs rose to $3.1 million compared with $934,000 in the same quarter last year.Organigram's loss from continuing operations amounted to $6.4 million or five cents per diluted share compared with a profit of $1.2 million or a penny per diluted share a year earlier.However, the company's profitability is "impressive" relative to others in the sector, said Jefferies analyst Owen Bennett, pointing to Organigram's adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $13.3 million."Q2 marks three consecutive quarters of positive adjusted EBITDA, which we expect to be viewed positively in the context of many peers who are currently loss-making or expected to be loss-making in the short term," Bennett said in a note to clients. Companies in this story: (TSXV:OGI) Armina Ligaya, The Canadian Press

  • CNW Group6 days ago

    Cannabis Industry Projected Revenues Growing Faster Than Originally Expected

    PALM BEACH, Florida, April 15, 2019 /CNW/ -- A Green Flower cannabis industry article started off with this amazing statement: "The cannabis market is booming these days, now operating legally in a number of states and countries across the globe." Another industry publication, the Marijuana Business Daily, supported this proposition, based on more states in the U.S. and more countries in the world, legalizing the industry. The Green Flower article also mentioned: "(the) U.S. cannabis market to surpass $24 billion by 2025" and"Another study with projections for 2021 was conducted by the Brightfield Group.

  • CNW Group6 days ago

    Organigram Reports Second Quarter Fiscal 2019 Results; Record Net Revenue of $26.9 Million

    Record net revenue of $26.9 million or more than double the net revenue of Q1-2019 Adjusted gross margin of $16.0 million or 60% 1 Adjusted EBITDA of $13.3 million or adjusted EBITDA margin of 49% 1 As ...

  • CNW Group10 days ago

    U.S. Currently 2nd to China in Hemp Revenues Which Could Approach $6 Billion by 2020

    PALM BEACH, Florida , April 11, 2019 /CNW/ -- In recent industry reports , China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ( $1.0 billion ), Europe ...

  • 2 Marijuana Stocks That Are Growing Faster Than Canopy Growth (TSX:WEED)
    The Motley Fool11 days ago

    2 Marijuana Stocks That Are Growing Faster Than Canopy Growth (TSX:WEED)

    Small-cap marijuana stocks like Organigram Holdings Inc (TSXV:OGI) are growing by leaps and bounds.

  • Better Than Canopy Growth Corp (TSX:WEED): 2 Stocks That Have Outperformed the Cannabis Giant
    The Motley Fool13 days ago

    Better Than Canopy Growth Corp (TSX:WEED): 2 Stocks That Have Outperformed the Cannabis Giant

    Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has rallied by more than 50% in 2019, but how much higher can it go?

  • CNW Group13 days ago

    CBD Products Continue to Gain Traction in Markets Around the Globe

    Many pieces of research have linked cannabis to effectively treating certain medical conditions such as cancer, chronic pain, epilepsy, and multiple sclerosis. THC is the psychoactive derivative of the marijuana family, which falls under the cannabis plant. On the other hand, CBD falls under the hemp family, which is also derived from cannabis.

  • CNW Group13 days ago

    Organigram Holdings Inc. to Report Second Quarter Fiscal 2019 Results on April 15th, 2019

    MONCTON, NB , April 8, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed ...

  • CNW Group13 days ago

    Organigram Appoints Chief of Staff and Announces Other Management Changes

    MONCTON, NB, April 7, 2019 /CNW/ – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the recent appointment of strategy and operations consultant James Cavanagh as the Company's Chief of Staff. As Chief of Staff, Mr. Cavanagh will play a central role in supporting the Company's executive, helping direct the Company's overall strategy, resources and focus.

  • ACCESSWIRE17 days ago

    Cannabis Companies are Just Beginning to Expand Global Footprint

    HOUSTON, TX / ACCESSWIRE / April 4, 2019 / Over the next decade, spending on worldwide cannabis could reach $57 billion by 2027, according to Arcview Market Research and BDS Analytics. In their report, ...

  • GlobeNewswire17 days ago

    Canada Prepares for 420: Canadian Cannabis Companies Establishing an Online Presence

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks concludes our two part series looking at the Canadian cannabis landscape and the numerous companies ensuring not only a brick and mortar footprint, but also creating a significant online e-commerce presence as well. With the many supply shortages the Canadian cannabis market has faced since legalization last year, having the store’s menus and the capability of reserving products online for pickup just might be the way for Canadian cannabis consumers to beat the low inventory situation. Grab, a new legal cannabis app based in Canada, is set to launch in the Alberta and Ontario markets this April.

  • Baystreet18 days ago

    OrganiGram, PHX at 52-Week Highs

    MediPharm Labs Corp. (V.LABS) hit a new 52-week high of $3.92 Wednesday. The company announced today ...

  • CNW Group18 days ago

    Optimism Warranted as Projected Revenues for Global Cannabis Markets Continue Rising

    PALM BEACH, Florida, April 3, 2019 /CNW/ -- Articles projecting potential revenues for cannabis seem to continue to rise and rise and rise… The optimism is almost tangible… but they do seem to be backed up by the progress this market has seen in the last year alone. While the projections differ, they all forecast robust sales figures just over the horizon. Here are some of those projections in ascending order. One of the first such reports in The Rolling Stone, which said: "For years, experts have predicted that if the cannabis industry expands at its current rate, the American market will reach $20 billion by 2020.  Another article said: "… (the) U.S. cannabis market to surpass $24 billion by 2025" and"Another study with projections for 2021 was conducted by the Brightfield Group.

  • CNW Group18 days ago

    Organigram Releases Cross-Platform Mobile Application for Medical Patients

    MONCTON, NB, April 3, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis is pleased to announce the release of a cross-platform patient-focused mobile application (the "Organigram Mobile App" or the "Application"). The Application was designed to offer patients greater convenience in optimizing their medication regimen and stay up-to-date on products, programs and Company news.

  • CNW Group18 days ago

    Organigram announces resignation of Dr. Kenneth Mitton from Board of Directors

    MONCTON, NB, April 3, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis announces the resignation of Dr. Kenneth Mitton from the Company's Board of Directors. Dr. Mitton is a highly respected physician with more than 30 years' experience as a family doctor who joined the Organigram Board of Directors in 2014.

  • 3 Cannabis Stocks Under $10 a Share
    The Motley Fool20 days ago

    3 Cannabis Stocks Under $10 a Share

    Looking for breakout cannabis stocks? Check out Green Organic Dutchman Holdings Ltd (TSX:TGOD), OrganiGram Holdings Inc (TSXV:OGI), and Hexo Corp (TSX:HEXO).

  • CNW Group20 days ago

    CBD Continues to Accrue Credibility as Major Pharmacies Begin to Offer Products

    NEW YORK, April 1, 2019 /CNW/ -- Recently, Walgreens Boot Alliance decided to add cannabidiol, or CBD-based products to its stores following CVS Health in the addition. Walgreens plans to sell such products in 1,500 store locations across nine different states. The decision to add CBD products to their stores signifies how rapidly the CBD industry has grown, cannabis and its derivatives were illegal on both state and federal levels within the U.S. Now 33 states and the District of Columbia have legalized medical use.

  • Attention Investors: This Small-Cap Cannabis Company Is Already Profitable
    The Motley Fool21 days ago

    Attention Investors: This Small-Cap Cannabis Company Is Already Profitable

    OrganiGram Holdings Inc. (TSXV:OGI) has achieved something few of its peers have: profitability. Is the company a buy?

  • CNW Group24 days ago

    Organigram Provides Update on Debenture Conversion

    MONCTON, NB, March 27, 2019 /CNW/ - Organigram Holdings Inc. (the "Company") (TSX VENTURE: OGI) (OTCQX:OGRMF - News), today provided an update on its previously announced mandatory conversion (the "Conversion") of the Company's 6.0% convertible unsecured debentures due January 31, 2020 (the "Debentures") (OGI.DB). As announced on February 27, 2019, the Company elected to exercise its right under the Debenture Indenture between the Company and the TSX Trust Company dated as of January 31, 2018 (the "Indenture") governing the Debentures, to convert all of the principal amount outstanding of the remaining Debentures on April 1, 2019 (the "Conversion Date") into common shares of the Company (the "Common Shares").